<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "Nanoparticle delivery" OR "non-viral delivery"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32089747">Link</a></p><p><b>Date:</b> 2020-02-24</p><p><b>Authors:</b> Henriette S de Bruijn ...  Sabrina Oliveira</p><p><b>Journal:</b> Theranostics</p><p><b>IF (7 or above):</b> 8.02</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Targeted photodynamic therapy (PDT) has the potential to selectively damage tumor tissue and to increase tumor vessel permeability.  Here we characterize the tissue biodistribution of two EGFR-targeted nanobody-photosensitizer conjugates (NB-PS), the monovalent 7D12-PS and the biparatopic 7D12-9G8-P ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Critical considerations for targeting colorectal liver metastases with nanotechnology.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31566913">Link</a></p><p><b>Date:</b> 2019-09-30</p><p><b>Authors:</b> Usman Arshad ...  Andrew Owen</p><p><b>Journal:</b> Wiley Interdiscip Rev Nanomed Nanobiotechnol</p><p><b>IF (7 or above):</b> 7.58</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Colorectal cancer remains a significant cause of morbidity and mortality worldwide.  Half of all patients develop liver metastases, presenting unique challenges for their treatment.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32064335">Link</a></p><p><b>Date:</b> 2020-02-17</p><p><b>Authors:</b> Hongmei Chen ...  Tianmeng Sun</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CCR9</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: On the design of precision nanomedicines.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32042891">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Xiaohe Tian ...  Giuseppe Battaglia</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Tight control on the selectivity of nanoparticles' interaction with biological systems is paramount for the development of targeted therapies.  However, the large number of tunable parameters makes it difficult to identify optimal design "sweet spots" without guiding principles.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Poly(vinyl alcohol) boosting therapeutic potential of </h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32010792">Link</a></p><p><b>Date:</b> 2020-02-05</p><p><b>Authors:</b> Takahiro Nomoto ...  Nobuhiro Nishiyama</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> In the current clinical boron neutron capture therapy (BNCT), </p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Lymphatic endothelial cells prime naïve CD8</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31988323">Link</a></p><p><b>Date:</b> 2020-01-28</p><p><b>Authors:</b> Efthymia Vokali ...  Melody A Swartz</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Lymphatic endothelial cells (LECs) chemoattract naïve T cells and promote their survival in the lymph nodes, and can cross-present antigens to naïve CD8</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980606">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Koji M Nishiguchi ...  Toru Nakazawa</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.8</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Supplementing wildtype copies of functionally defective genes with adeno-associated virus (AAV) is a strategy being explored clinically for various retinal dystrophies.  However, the low cargo limit of this vector allows its use in only a fraction of patients with mutations in relatively small patho ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Roles of circRNAs in the tumour microenvironment.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31973726">Link</a></p><p><b>Date:</b> 2020-01-24</p><p><b>Authors:</b> Qiuge Zhang ...  Zhenqiang Sun</p><p><b>Journal:</b> Mol. Cancer</p><p><b>IF (7 or above):</b> 11.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The tumour microenvironment (TME) constitutes the area surrounding the tumour during its development and has been demonstrated to play roles in cancer-related diseases through crosstalk with tumour cells.  Circular RNAs (circRNAs) are a subpopulation of endogenous noncoding RNAs (ncRNAs) that are ub ....</p></div></td></div></tr></table></div><hr></div></body></html>